- EMV Capital Ltd (EMVC) is a London-based pan-European investor founded in 2018.
- EMVC are focused on B2B companies in the industrial high-tech, clean energy, resource efficiency, circular economy, smart cities and transportation sectors.
- EMVC works with companies that are pre-Series A, Series A, early growth and special situations.
About EMV Capital
EMVC invests in, and provides advisory services related to, investments that involve a range of technologies including robotics and AI, machine vision, materials science, IoT, advanced engineering and power electronics. EMVC’s model is to develop a customized investment strategy for each company, combining its network of investors from Family Offices, Wealth Managers, Institutional VC investors and Corporate VC funds.
EMV Capital was founded by Dr. Ilian Iliev and has a team with expertise in investment, deep industry, corporate finance and M&A. EMV Capital Limited is an appointed representative of Sapphire Capital Limited, which is authorised and regulated by the Financial Conduct Authority. EMV Capital is also exclusive advisor to the EMVC Evergreen EIS Fund.
EMVC works with companies that are pre-Series A, Series A, early growth and special situations. The company develops a customized investment strategy for each company. EMVC syndicates investment sources from the EMV EIS Fund, and network of investors from Family Offices, Wealth Managers, institutional VC investors and Corporate VC funds. This ensures that the businesses they work with have access to the right type and scale of investment appropriate to their stage of investment.
More from VCs
EMV Capital Portfolio
Since its 2018 foundation, EMV Capital has made a total of 18 investments. Their most recent investment was on May 20, 2021, when PointGrab, who develop machine learning sensors that provide organisations accurate data about the count and location of people in the offices, raised £3.4M in a venture funding round.
EMV Capital has had 2 exits. EMV Capital’s exits include Vortex Biosciences, an oncology diagnostics company that integrates cancer biology, microfluidic engineering, and Wanda Inc, a technology company providing applications and machine learning based health informatics for remote health and patient management.